BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 10477457)

  • 1. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
    Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
    Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
    Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
    Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5).
    Gris JC; Quéré I; Monpeyroux F; Mercier E; Ripart-Neveu S; Tailland ML; Hoffet M; Berlan J; Daurès JP; Marès P
    Thromb Haemost; 1999 Jun; 81(6):891-9. PubMed ID: 10404763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece.
    Zalavras ChG; Giotopoulou S; Dokou E; Mitsis M; Ioannou HV; Tzolou A; Kolaitis N; Vartholomatos G
    Int Angiol; 2002 Sep; 21(3):268-71. PubMed ID: 12384649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.
    de Franchis R; Fermo I; Mazzola G; Sebastio G; Di Minno G; Coppola A; Andria G; D'Angelo A
    Thromb Haemost; 2000 Oct; 84(4):576-82. PubMed ID: 11057853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis.
    Balta G; Gürgey A
    Turk J Pediatr; 1999; 41(2):197-9. PubMed ID: 10770658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
    Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
    Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The C677T mutation in the methylenetetrahydrofolate reductase gene and its association with deep vein thrombophilia in Shandong Hans].
    Guo C; Guo Q; Gong Y; Chen B; Liu Q; Li J; Gao G; Zhou H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):295-7. PubMed ID: 12170465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thrombotic risk factors in end-stage renal disease.
    Tripathi G; Sankhwar SN; Sharma RK; Baburaj VP; Agrawal S
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):132-40. PubMed ID: 19520684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C677T genetic polymorphism of methylenetetrahydrofolate reductase in premature coronary heart disease].
    Xu H; Chen Z; Tang J; Zhu D; Zhang C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):118-21. PubMed ID: 12569666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of the 677 C-->T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients.
    Adekile AD; Kutlar F; Haider MZ; Kutlar A
    Am J Hematol; 2001 Apr; 66(4):263-6. PubMed ID: 11279637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Tsai AW; Cushman M; Tsai MY; Heckbert SR; Rosamond WD; Aleksic N; Yanez ND; Psaty BM; Folsom AR
    Am J Hematol; 2003 Mar; 72(3):192-200. PubMed ID: 12605391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
    Fukasawa M; Matsushita K; Kamiyama M; Mikami Y; Araki I; Yamagata Z; Takeda M
    Am J Kidney Dis; 2003 Mar; 41(3):637-42. PubMed ID: 12612987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.